BK virus nephropathy is not always alone.

Area of Science:

• Nephrology
• Transplant Immunology
• Virology

Background:

• BK virus-associated nephropathy (BKVAN) is a significant cause of kidney allograft loss, particularly within the first year post-transplant.
• Over-immunosuppression increases patient susceptibility to opportunistic viral infections.

Purpose of the Study:

• To investigate the incidence of BK viremia and BKVAN in renal transplant recipients.
• To assess the relationship between immunosuppression protocols and the development of BKVAN.

Main Methods:

• An observational study conducted between January 2013 and December 2014.
• Patients received either intensive desensitization therapy (including ATG, RITU, basiliximab, TPE, MTP) for high-risk cases or MTP alone for low-risk cases.

Main Results:

• Out of 26 patients, BKVAN and BK viremia occurred in 3 and 2 patients respectively among those receiving intensive desensitization protocols.
• One patient in the low-risk group developed BKVAN.
• Associated opportunistic infections like CMV, parvovirus B19, and syndromes such as HPS and TMA were observed.

Conclusions:

• Increased awareness of BK virus nephropathy is crucial for timely management.
• Optimizing immunosuppression strategies and minimizing over-immunosuppression are key to preventing BKVAN.
• Vigilance for other opportunistic infections and specific syndromes in BKVAN patients is essential.